[Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?].
Identifieur interne : 000578 ( Ncbi/Curation ); précédent : 000577; suivant : 000579[Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?].
Auteurs : M W Kramer ; M. Wolters ; I F Abdelkawi ; A S Merseburger ; U. Nagele ; A. Gross ; T. Bach ; M A Kuczyk ; T R W. HerrmannSource :
- Der Urologe. Ausg. A [ 1433-0563 ] ; 2012.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Muscles lisses, Tumeurs de la vessie urinaire, Urothélium.
- Cystectomie, Humains, Tumeurs de la vessie urinaire, Urothélium, Urètre.
English descriptors
- KwdEn :
- MESH :
- methods : Cystectomy.
- pathology : Muscle, Smooth, Urinary Bladder Neoplasms, Urothelium.
- surgery : Urethra, Urinary Bladder Neoplasms, Urothelium.
- Humans.
Abstract
Bladder cancer of the urothelium is the second most common malignancy among urological tumors. In view of a worldwide aging population and the fact that increased incidence rates are associated with higher age, new socioeconomic challenges will appear. Even nowadays the treatment of bladder cancer bears the highest lifetime treatment costs per patient among all forms of cancer. In conjunction with higher comorbidity rates among older patients urologists are facing new challenges in the treatment and care of patients with bladder cancer. The standard treatment for non-muscle invasive bladder cancer (NMIBC) is monopolar transurethral resection using resection loops (TURB). Based on experience in the surgical treatment of benign prostatic hyperplasia, different concepts of en bloc resection of bladder tumors using alternative energy resources (e.g. holmium laser, thulium laser and the water-jet HybridKnife) have been developed. Goals of new treatment modalities are reduction of perioperative and postoperative comorbidities, better pathological work-up of the specimens and increased recurrence-free survival. Postulated advantages using laser devices are a more precise cutting line as well as better hemostasis. The evidential value of this review is limited due to the lack of randomized, prospective studies. However, there is a tendency towards a limitation of perioperative and postoperative morbidities as well as higher chance of well-preserved tissues for better pathohistological evaluation using en bloc resection methods. More studies with long-term follow-up periods and better randomization are needed to clarify whether en bloc strategies provide better long-term oncological survival.
DOI: 10.1007/s00120-012-2876-8
PubMed: 22622487
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000364
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000364
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000364
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000578
Links to Exploration step
pubmed:22622487Curation
No country items
M W Kramer<affiliation><nlm:affiliation>Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover.</nlm:affiliation><wicri:noCountry code="subField">Hannover</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?].</title><author><name sortKey="Kramer, M W" sort="Kramer, M W" uniqKey="Kramer M" first="M W" last="Kramer">M W Kramer</name><affiliation><nlm:affiliation>Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover.</nlm:affiliation><wicri:noCountry code="subField">Hannover</wicri:noCountry></affiliation></author><author><name sortKey="Wolters, M" sort="Wolters, M" uniqKey="Wolters M" first="M" last="Wolters">M. Wolters</name></author><author><name sortKey="Abdelkawi, I F" sort="Abdelkawi, I F" uniqKey="Abdelkawi I" first="I F" last="Abdelkawi">I F Abdelkawi</name></author><author><name sortKey="Merseburger, A S" sort="Merseburger, A S" uniqKey="Merseburger A" first="A S" last="Merseburger">A S Merseburger</name></author><author><name sortKey="Nagele, U" sort="Nagele, U" uniqKey="Nagele U" first="U" last="Nagele">U. Nagele</name></author><author><name sortKey="Gross, A" sort="Gross, A" uniqKey="Gross A" first="A" last="Gross">A. Gross</name></author><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name></author><author><name sortKey="Kuczyk, M A" sort="Kuczyk, M A" uniqKey="Kuczyk M" first="M A" last="Kuczyk">M A Kuczyk</name></author><author><name sortKey="Herrmann, T R W" sort="Herrmann, T R W" uniqKey="Herrmann T" first="T R W" last="Herrmann">T R W. Herrmann</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="doi">10.1007/s00120-012-2876-8</idno><idno type="RBID">pubmed:22622487</idno><idno type="pmid">22622487</idno><idno type="wicri:Area/PubMed/Corpus">000364</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000364</idno><idno type="wicri:Area/PubMed/Curation">000364</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000364</idno><idno type="wicri:Area/PubMed/Checkpoint">000364</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000364</idno><idno type="wicri:Area/Ncbi/Merge">000578</idno><idno type="wicri:Area/Ncbi/Curation">000578</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?].</title><author><name sortKey="Kramer, M W" sort="Kramer, M W" uniqKey="Kramer M" first="M W" last="Kramer">M W Kramer</name><affiliation><nlm:affiliation>Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover.</nlm:affiliation><wicri:noCountry code="subField">Hannover</wicri:noCountry></affiliation></author><author><name sortKey="Wolters, M" sort="Wolters, M" uniqKey="Wolters M" first="M" last="Wolters">M. Wolters</name></author><author><name sortKey="Abdelkawi, I F" sort="Abdelkawi, I F" uniqKey="Abdelkawi I" first="I F" last="Abdelkawi">I F Abdelkawi</name></author><author><name sortKey="Merseburger, A S" sort="Merseburger, A S" uniqKey="Merseburger A" first="A S" last="Merseburger">A S Merseburger</name></author><author><name sortKey="Nagele, U" sort="Nagele, U" uniqKey="Nagele U" first="U" last="Nagele">U. Nagele</name></author><author><name sortKey="Gross, A" sort="Gross, A" uniqKey="Gross A" first="A" last="Gross">A. Gross</name></author><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name></author><author><name sortKey="Kuczyk, M A" sort="Kuczyk, M A" uniqKey="Kuczyk M" first="M A" last="Kuczyk">M A Kuczyk</name></author><author><name sortKey="Herrmann, T R W" sort="Herrmann, T R W" uniqKey="Herrmann T" first="T R W" last="Herrmann">T R W. Herrmann</name></author></analytic><series><title level="j">Der Urologe. Ausg. A</title><idno type="eISSN">1433-0563</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cystectomy (methods)</term><term>Humans</term><term>Muscle, Smooth (pathology)</term><term>Urethra (surgery)</term><term>Urinary Bladder Neoplasms (pathology)</term><term>Urinary Bladder Neoplasms (surgery)</term><term>Urothelium (pathology)</term><term>Urothelium (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Cystectomie ()</term><term>Humains</term><term>Muscles lisses (anatomopathologie)</term><term>Tumeurs de la vessie urinaire ()</term><term>Tumeurs de la vessie urinaire (anatomopathologie)</term><term>Urothélium ()</term><term>Urothélium (anatomopathologie)</term><term>Urètre ()</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Muscles lisses</term><term>Tumeurs de la vessie urinaire</term><term>Urothélium</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Cystectomy</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Muscle, Smooth</term><term>Urinary Bladder Neoplasms</term><term>Urothelium</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Urethra</term><term>Urinary Bladder Neoplasms</term><term>Urothelium</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Cystectomie</term><term>Humains</term><term>Tumeurs de la vessie urinaire</term><term>Urothélium</term><term>Urètre</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Bladder cancer of the urothelium is the second most common malignancy among urological tumors. In view of a worldwide aging population and the fact that increased incidence rates are associated with higher age, new socioeconomic challenges will appear. Even nowadays the treatment of bladder cancer bears the highest lifetime treatment costs per patient among all forms of cancer. In conjunction with higher comorbidity rates among older patients urologists are facing new challenges in the treatment and care of patients with bladder cancer. The standard treatment for non-muscle invasive bladder cancer (NMIBC) is monopolar transurethral resection using resection loops (TURB). Based on experience in the surgical treatment of benign prostatic hyperplasia, different concepts of en bloc resection of bladder tumors using alternative energy resources (e.g. holmium laser, thulium laser and the water-jet HybridKnife) have been developed. Goals of new treatment modalities are reduction of perioperative and postoperative comorbidities, better pathological work-up of the specimens and increased recurrence-free survival. Postulated advantages using laser devices are a more precise cutting line as well as better hemostasis. The evidential value of this review is limited due to the lack of randomized, prospective studies. However, there is a tendency towards a limitation of perioperative and postoperative morbidities as well as higher chance of well-preserved tissues for better pathohistological evaluation using en bloc resection methods. More studies with long-term follow-up periods and better randomization are needed to clarify whether en bloc strategies provide better long-term oncological survival.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000578 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000578 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:22622487
|texte= [Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:22622487" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |